Skip to main content
Log in

Spontaneous regression of hypercalcemia in a patient with primary hyperparathyroidism and prolactinoma

  • Case Report
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

We describe a unique case of spontaneous resolution of hyperparathyroidism in a lady with combined parathyroid adenoma and prolactinoma, raising the possibility of underlying multiple endocrine neoplasia (MEN) 1 syndrome. We also discuss the mechanism and natural history of such spontaneous remission.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Marx SJ. Hyperparathyroid and hypoparathyroid disorders. N Engl J Med 2000, 343: 1863–75.

    Article  CAS  PubMed  Google Scholar 

  2. Mir R, Gerold T, Khan S, Weitz J. Spontaneous infarction of parathyroid adenoma: Case report and literature review. Head Neck 1993, 15: 566–68.

    Article  CAS  PubMed  Google Scholar 

  3. Natsui K, Tanaka K, Suda M, et al. Spontaneous remission of primary hyperparathyroidism due to hemorrhagic infarction in the parathyroid adenoma. Intern Med 1996, 35: 646–49.

    Article  CAS  PubMed  Google Scholar 

  4. Mizunashi K, Takaya K, Suda M, et al. The time course of renal function and bone turnover in parathyroid crisis due to intratumoral hemorrhage. Clin Invest 1994, 72: 448–50.

    CAS  Google Scholar 

  5. Johnston CC Jr, Schnute RB. A case of primary hyperparathyroidism with spontaneous remission following infarction of the adenoma with development of hypocalcaemic tetany. J Clin Endocrinol 1961, 21: 196–200.

    Article  Google Scholar 

  6. Miller DL, Doppman JL, Chang R, et al. Angiographic ablation of parathyroid adenomas: lessons from 10 year experience. Radiology 1987, 165: 601–7.

    CAS  PubMed  Google Scholar 

  7. Broadus AE, Horst RL, Littledike ET, Mahaffey JE, Rasmussen H. Primary hyperparathyroidism with intermittent hypercalcemia: serial observations and simple diagnosis by means of an oral calcium tolerance test. Clin Endocrinol (Oxf) 1980, 12: 225–35.

    Article  CAS  Google Scholar 

  8. Nordenstrom E, Westerdahl J, Isaksson A, Lindblom P, Bergenfelz A. Patients with elevated serum parathyroid hormone levels after parathyroidectomy: showing signs of decreased peripheral parathyroid hormone sensitivity. World J Surg 2003, 27: 212–5.

    PubMed  Google Scholar 

  9. Minisola S, Rosso R, Romagnoli E, et al. Trabecular bone mineral density in primary hyperparathyroidism: relationship to clinical presentation and biomarkers of skeletal turnover. Bone Miner 1993, 20: 113–23.

    Article  CAS  PubMed  Google Scholar 

  10. Pirano B, Chen T, Cooperstein L, Serge G, Puschett J. Fractures and vertebral bone mineral density in patients with renal osteodystrophy. Clin Nephrol 1988, 30: 57–62.

    Google Scholar 

  11. Kaye M, Pritchard JE, Halpenny GW, Light W. Bone disease in chronic renal failure with particular reference to osteosclerosis. Medicine 1960, 39: 157–90.

    Article  CAS  PubMed  Google Scholar 

  12. Jabbour N, Corvilain J, Fuss M, Kinnaert P, Van Geetruyden J. The natural history of renal stone disease after parathyroidectomy for primary hyperparathyroidism. Surgery 1991, 172: 25–8.

    CAS  Google Scholar 

  13. Mollerup CL, Vestergaard P, Frokjaer VG, et al. Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study. Brit Med J 2002, 325: 807–11.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V. Baskar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baskar, V., Kamalakannan, D., Singh, B.M. et al. Spontaneous regression of hypercalcemia in a patient with primary hyperparathyroidism and prolactinoma. J Endocrinol Invest 27, 462–464 (2004). https://doi.org/10.1007/BF03345292

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03345292

Key-words

Navigation